Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Breast Neoplasms 12Brain Neoplasms 6Breast Neoplasms, Male 5Glioblastoma 4Gliosarcoma 3Stomach Neoplasms 2Squamous Cell Carcinoma of Head and Neck 2Salivary Gland Neoplasms 2Prostatic Neoplasms 2Oligodendroglioma 2Glioma 2Gallbladder Neoplasms 2Ependymoma 2Carcinoma, Hepatocellular 2Bile Duct Neoplasms 2Astrocytoma 2Tongue Neoplasms 1Thyroid Neoplasms 1Thymoma 1Spinal Cord Neoplasms 1Small Cell Lung Carcinoma 1Skin Neoplasms 1Neoplasms 1Melanoma 1Medulloblastoma 1Insulin-Like Growth Factor I, Resistance To 1Familial ependymoma 1Esophageal Neoplasms 1Endometrial Neoplasms 1Central Nervous System Neoplasms 1

Interventions

Specimen Handling 10Magnetic Resonance Spectroscopy 9Carboplatin 9Taxes 7Paclitaxel 7Biopsy 7temsirolimus 6Trastuzumab 5Sirolimus 5pembrolizumab 4Radiotherapy 4olaparib 3Nivolumab 3Interleukin-12 Subunit p35 3Bevacizumab 3pertuzumab 2palbociclib 2ipatasertib 2binimetinib 2aldesleukin 2X-Rays 2Thalidomide 2Reverse Transcriptase Polymerase Chain Reaction 2Oxaliplatin 2Megestrol Acetate 2Interleukin-12 2Immunoglobulin G 2Fluorouracil 2Docetaxel 2Disulfides 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Endometrial Neoplasms × Lapatinib × Clear all
NCT00096447 2019-07-24

Lapatinib in Treating Patients With Recurrent or Persistent Endometrial Cancer

National Cancer Institute (NCI)

Phase 2 Completed
31 enrolled 13 charts
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡